Global DPT Vaccines Market Insights and Forecast to 2031

Report ID: 1227428 | Published Date: Jan 2025 | No. of Page: 96 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 DPT Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global DPT Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 DTaP
        1.2.3 Tdap
        1.2.4 DTwP
    1.3 Market by Age
        1.3.1 Global DPT Vaccines Market Size Growth Rate by Age, 2017 VS 2021 VS 2028
        1.3.2 12 Months Below
        1.3.3 12 Months Above
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global DPT Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global DPT Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global DPT Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global DPT Vaccines Sales by Region
        2.4.1 Global DPT Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales DPT Vaccines by Region (2023-2028)
    2.5 Global DPT Vaccines Revenue by Region
        2.5.1 Global DPT Vaccines Revenue by Region (2017-2022)
        2.5.2 Global DPT Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global DPT Vaccines Sales by Manufacturers
        3.1.1 Global Top DPT Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global DPT Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of DPT Vaccines in 2021
    3.2 Global DPT Vaccines Revenue by Manufacturers
        3.2.1 Global DPT Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global DPT Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by DPT Vaccines Revenue in 2021
    3.3 Global DPT Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global DPT Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global DPT Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global DPT Vaccines Sales by Type
        4.1.1 Global DPT Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global DPT Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global DPT Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global DPT Vaccines Revenue by Type
        4.2.1 Global DPT Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global DPT Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global DPT Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global DPT Vaccines Price by Type
        4.3.1 Global DPT Vaccines Price by Type (2017-2022)
        4.3.2 Global DPT Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Age
    5.1 Global DPT Vaccines Sales by Age
        5.1.1 Global DPT Vaccines Historical Sales by Age (2017-2022)
        5.1.2 Global DPT Vaccines Forecasted Sales by Age (2023-2028)
        5.1.3 Global DPT Vaccines Sales Market Share by Age (2017-2028)
    5.2 Global DPT Vaccines Revenue by Age
        5.2.1 Global DPT Vaccines Historical Revenue by Age (2017-2022)
        5.2.2 Global DPT Vaccines Forecasted Revenue by Age (2023-2028)
        5.2.3 Global DPT Vaccines Revenue Market Share by Age (2017-2028)
    5.3 Global DPT Vaccines Price by Age
        5.3.1 Global DPT Vaccines Price by Age (2017-2022)
        5.3.2 Global DPT Vaccines Price Forecast by Age (2023-2028)
6 North America
    6.1 North America DPT Vaccines Market Size by Type
        6.1.1 North America DPT Vaccines Sales by Type (2017-2028)
        6.1.2 North America DPT Vaccines Revenue by Type (2017-2028)
    6.2 North America DPT Vaccines Market Size by Age
        6.2.1 North America DPT Vaccines Sales by Age (2017-2028)
        6.2.2 North America DPT Vaccines Revenue by Age (2017-2028)
    6.3 North America DPT Vaccines Market Size by Country
        6.3.1 North America DPT Vaccines Sales by Country (2017-2028)
        6.3.2 North America DPT Vaccines Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe DPT Vaccines Market Size by Type
        7.1.1 Europe DPT Vaccines Sales by Type (2017-2028)
        7.1.2 Europe DPT Vaccines Revenue by Type (2017-2028)
    7.2 Europe DPT Vaccines Market Size by Age
        7.2.1 Europe DPT Vaccines Sales by Age (2017-2028)
        7.2.2 Europe DPT Vaccines Revenue by Age (2017-2028)
    7.3 Europe DPT Vaccines Market Size by Country
        7.3.1 Europe DPT Vaccines Sales by Country (2017-2028)
        7.3.2 Europe DPT Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific DPT Vaccines Market Size by Type
        8.1.1 Asia Pacific DPT Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific DPT Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific DPT Vaccines Market Size by Age
        8.2.1 Asia Pacific DPT Vaccines Sales by Age (2017-2028)
        8.2.2 Asia Pacific DPT Vaccines Revenue by Age (2017-2028)
    8.3 Asia Pacific DPT Vaccines Market Size by Region
        8.3.1 Asia Pacific DPT Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific DPT Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America DPT Vaccines Market Size by Type
        9.1.1 Latin America DPT Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America DPT Vaccines Revenue by Type (2017-2028)
    9.2 Latin America DPT Vaccines Market Size by Age
        9.2.1 Latin America DPT Vaccines Sales by Age (2017-2028)
        9.2.2 Latin America DPT Vaccines Revenue by Age (2017-2028)
    9.3 Latin America DPT Vaccines Market Size by Country
        9.3.1 Latin America DPT Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America DPT Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa DPT Vaccines Market Size by Type
        10.1.1 Middle East and Africa DPT Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa DPT Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa DPT Vaccines Market Size by Age
        10.2.1 Middle East and Africa DPT Vaccines Sales by Age (2017-2028)
        10.2.2 Middle East and Africa DPT Vaccines Revenue by Age (2017-2028)
    10.3 Middle East and Africa DPT Vaccines Market Size by Country
        10.3.1 Middle East and Africa DPT Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa DPT Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sanofi Pasteur
        11.1.1 Sanofi Pasteur Corporation Information
        11.1.2 Sanofi Pasteur Overview
        11.1.3 Sanofi Pasteur DPT Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sanofi Pasteur DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi Pasteur Recent Developments
    11.2 GSK
        11.2.1 GSK Corporation Information
        11.2.2 GSK Overview
        11.2.3 GSK DPT Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GSK DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GSK Recent Developments
    11.3 Mitsubishi Tanabe Pharma
        11.3.1 Mitsubishi Tanabe Pharma Corporation Information
        11.3.2 Mitsubishi Tanabe Pharma Overview
        11.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Mitsubishi Tanabe Pharma Recent Developments
    11.4 KM Biologics
        11.4.1 KM Biologics Corporation Information
        11.4.2 KM Biologics Overview
        11.4.3 KM Biologics DPT Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 KM Biologics DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 KM Biologics Recent Developments
    11.5 Wuhan Institute of Biological Products
        11.5.1 Wuhan Institute of Biological Products Corporation Information
        11.5.2 Wuhan Institute of Biological Products Overview
        11.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Wuhan Institute of Biological Products Recent Developments
    11.6 Walvax Biotechnology
        11.6.1 Walvax Biotechnology Corporation Information
        11.6.2 Walvax Biotechnology Overview
        11.6.3 Walvax Biotechnology DPT Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Walvax Biotechnology DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Walvax Biotechnology Recent Developments
    11.7 Chengdu Institute of Biological Products
        11.7.1 Chengdu Institute of Biological Products Corporation Information
        11.7.2 Chengdu Institute of Biological Products Overview
        11.7.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Chengdu Institute of Biological Products DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Chengdu Institute of Biological Products Recent Developments
    11.8 Minhai Biotechnology
        11.8.1 Minhai Biotechnology Corporation Information
        11.8.2 Minhai Biotechnology Overview
        11.8.3 Minhai Biotechnology DPT Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Minhai Biotechnology DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Minhai Biotechnology Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 DPT Vaccines Industry Chain Analysis
    12.2 DPT Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 DPT Vaccines Production Mode & Process
    12.4 DPT Vaccines Sales and Marketing
        12.4.1 DPT Vaccines Sales Channels
        12.4.2 DPT Vaccines Distributors
    12.5 DPT Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 DPT Vaccines Industry Trends
    13.2 DPT Vaccines Market Drivers
    13.3 DPT Vaccines Market Challenges
    13.4 DPT Vaccines Market Restraints
14 Key Findings in The Global DPT Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global DPT Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of DTaP
    Table 3. Major Manufacturers of Tdap
    Table 4. Major Manufacturers of DTwP
    Table 5. Global DPT Vaccines Market Size Growth Rate by Age, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global DPT Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global DPT Vaccines Sales by Region (2017-2022) & (M Doses)
    Table 8. Global DPT Vaccines Sales Market Share by Region (2017-2022)
    Table 9. Global DPT Vaccines Sales by Region (2023-2028) & (M Doses)
    Table 10. Global DPT Vaccines Sales Market Share by Region (2023-2028)
    Table 11. Global DPT Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global DPT Vaccines Revenue Market Share by Region (2017-2022)
    Table 13. Global DPT Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global DPT Vaccines Revenue Market Share by Region (2023-2028)
    Table 15. Global DPT Vaccines Sales by Manufacturers (2017-2022) & (M Doses)
    Table 16. Global DPT Vaccines Sales Share by Manufacturers (2017-2022)
    Table 17. Global DPT Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global DPT Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 19. DPT Vaccines Price by Manufacturers (2017-2022) &(US$/Dose)
    Table 20. Global DPT Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global DPT Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DPT Vaccines as of 2021)
    Table 22. DPT Vaccines Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers DPT Vaccines Product Offered
    Table 24. Date of Manufacturers Enter into DPT Vaccines Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global DPT Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 27. Global DPT Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 28. Global DPT Vaccines Sales Share by Type (2017-2022)
    Table 29. Global DPT Vaccines Sales Share by Type (2023-2028)
    Table 30. Global DPT Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global DPT Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global DPT Vaccines Revenue Share by Type (2017-2022)
    Table 33. Global DPT Vaccines Revenue Share by Type (2023-2028)
    Table 34. DPT Vaccines Price by Type (2017-2022) & (US$/Dose)
    Table 35. Global DPT Vaccines Price Forecast by Type (2023-2028) & (US$/Dose)
    Table 36. Global DPT Vaccines Sales by Age (2017-2022) & (M Doses)
    Table 37. Global DPT Vaccines Sales by Age (2023-2028) & (M Doses)
    Table 38. Global DPT Vaccines Sales Share by Age (2017-2022)
    Table 39. Global DPT Vaccines Sales Share by Age (2023-2028)
    Table 40. Global DPT Vaccines Revenue by Age (2017-2022) & (US$ Million)
    Table 41. Global DPT Vaccines Revenue by Age (2023-2028) & (US$ Million)
    Table 42. Global DPT Vaccines Revenue Share by Age (2017-2022)
    Table 43. Global DPT Vaccines Revenue Share by Age (2023-2028)
    Table 44. DPT Vaccines Price by Age (2017-2022) & (US$/Dose)
    Table 45. Global DPT Vaccines Price Forecast by Age (2023-2028) & (US$/Dose)
    Table 46. North America DPT Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 47. North America DPT Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 48. North America DPT Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America DPT Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America DPT Vaccines Sales by Age (2017-2022) & (M Doses)
    Table 51. North America DPT Vaccines Sales by Age (2023-2028) & (M Doses)
    Table 52. North America DPT Vaccines Revenue by Age (2017-2022) & (US$ Million)
    Table 53. North America DPT Vaccines Revenue by Age (2023-2028) & (US$ Million)
    Table 54. North America DPT Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 55. North America DPT Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 56. North America DPT Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America DPT Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe DPT Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 59. Europe DPT Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 60. Europe DPT Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe DPT Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe DPT Vaccines Sales by Age (2017-2022) & (M Doses)
    Table 63. Europe DPT Vaccines Sales by Age (2023-2028) & (M Doses)
    Table 64. Europe DPT Vaccines Revenue by Age (2017-2022) & (US$ Million)
    Table 65. Europe DPT Vaccines Revenue by Age (2023-2028) & (US$ Million)
    Table 66. Europe DPT Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 67. Europe DPT Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 68. Europe DPT Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe DPT Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific DPT Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 71. Asia Pacific DPT Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 72. Asia Pacific DPT Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific DPT Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific DPT Vaccines Sales by Age (2017-2022) & (M Doses)
    Table 75. Asia Pacific DPT Vaccines Sales by Age (2023-2028) & (M Doses)
    Table 76. Asia Pacific DPT Vaccines Revenue by Age (2017-2022) & (US$ Million)
    Table 77. Asia Pacific DPT Vaccines Revenue by Age (2023-2028) & (US$ Million)
    Table 78. Asia Pacific DPT Vaccines Sales by Region (2017-2022) & (M Doses)
    Table 79. Asia Pacific DPT Vaccines Sales by Region (2023-2028) & (M Doses)
    Table 80. Asia Pacific DPT Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific DPT Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America DPT Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 83. Latin America DPT Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 84. Latin America DPT Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America DPT Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America DPT Vaccines Sales by Age (2017-2022) & (M Doses)
    Table 87. Latin America DPT Vaccines Sales by Age (2023-2028) & (M Doses)
    Table 88. Latin America DPT Vaccines Revenue by Age (2017-2022) & (US$ Million)
    Table 89. Latin America DPT Vaccines Revenue by Age (2023-2028) & (US$ Million)
    Table 90. Latin America DPT Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 91. Latin America DPT Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 92. Latin America DPT Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America DPT Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa DPT Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 95. Middle East and Africa DPT Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 96. Middle East and Africa DPT Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa DPT Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa DPT Vaccines Sales by Age (2017-2022) & (M Doses)
    Table 99. Middle East and Africa DPT Vaccines Sales by Age (2023-2028) & (M Doses)
    Table 100. Middle East and Africa DPT Vaccines Revenue by Age (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa DPT Vaccines Revenue by Age (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa DPT Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 103. Middle East and Africa DPT Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 104. Middle East and Africa DPT Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa DPT Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Sanofi Pasteur Corporation Information
    Table 107. Sanofi Pasteur Description and Major Businesses
    Table 108. Sanofi Pasteur DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 109. Sanofi Pasteur DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Sanofi Pasteur Recent Developments
    Table 111. GSK Corporation Information
    Table 112. GSK Description and Major Businesses
    Table 113. GSK DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 114. GSK DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. GSK Recent Developments
    Table 116. Mitsubishi Tanabe Pharma Corporation Information
    Table 117. Mitsubishi Tanabe Pharma Description and Major Businesses
    Table 118. Mitsubishi Tanabe Pharma DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 119. Mitsubishi Tanabe Pharma DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Mitsubishi Tanabe Pharma Recent Developments
    Table 121. KM Biologics Corporation Information
    Table 122. KM Biologics Description and Major Businesses
    Table 123. KM Biologics DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 124. KM Biologics DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. KM Biologics Recent Developments
    Table 126. Wuhan Institute of Biological Products Corporation Information
    Table 127. Wuhan Institute of Biological Products Description and Major Businesses
    Table 128. Wuhan Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 129. Wuhan Institute of Biological Products DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Wuhan Institute of Biological Products Recent Developments
    Table 131. Walvax Biotechnology Corporation Information
    Table 132. Walvax Biotechnology Description and Major Businesses
    Table 133. Walvax Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 134. Walvax Biotechnology DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Walvax Biotechnology Recent Developments
    Table 136. Chengdu Institute of Biological Products Corporation Information
    Table 137. Chengdu Institute of Biological Products Description and Major Businesses
    Table 138. Chengdu Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 139. Chengdu Institute of Biological Products DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Chengdu Institute of Biological Products Recent Developments
    Table 141. Minhai Biotechnology Corporation Information
    Table 142. Minhai Biotechnology Description and Major Businesses
    Table 143. Minhai Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 144. Minhai Biotechnology DPT Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Minhai Biotechnology Recent Developments
    Table 146. Key Raw Materials Lists
    Table 147. Raw Materials Key Suppliers Lists
    Table 148. DPT Vaccines Distributors List
    Table 149. DPT Vaccines Customers List
    Table 150. DPT Vaccines Market Trends
    Table 151. DPT Vaccines Market Drivers
    Table 152. DPT Vaccines Market Challenges
    Table 153. DPT Vaccines Market Restraints
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. DPT Vaccines Product Picture
    Figure 3. Global DPT Vaccines Market Share by Type in 2021 & 2028
    Figure 3. DTaP Product Picture
    Figure 4. Tdap Product Picture
    Figure 5. DTwP Product Picture
    Figure 6. Global DPT Vaccines Market Share by Age in 2021 & 2028
    Figure 7. 12 Months Below
    Figure 8. 12 Months Above
    Figure 9. DPT Vaccines Report Years Considered
    Figure 10. Global DPT Vaccines Sales 2017-2028 (M Doses)
    Figure 11. Global DPT Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global DPT Vaccines Revenue 2017-2028 (US$ Million)
    Figure 13. Global DPT Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global DPT Vaccines Sales Market Share by Region (2017-2022)
    Figure 15. Global DPT Vaccines Sales Market Share by Region (2023-2028)
    Figure 16. North America DPT Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 17. North America DPT Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe DPT Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 19. Europe DPT Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific DPT Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 21. Asia-Pacific DPT Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America DPT Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 23. Latin America DPT Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa DPT Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 25. Middle East & Africa DPT Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The DPT Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of DPT Vaccines in the World: Market Share by DPT Vaccines Revenue in 2021
    Figure 28. Global DPT Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global DPT Vaccines Sales Market Share by Type (2017-2028)
    Figure 30. Global DPT Vaccines Revenue Market Share by Type (2017-2028)
    Figure 31. Global DPT Vaccines Sales Market Share by Age (2017-2028)
    Figure 32. Global DPT Vaccines Revenue Market Share by Age (2017-2028)
    Figure 33. North America DPT Vaccines Sales Market Share by Type (2017-2028)
    Figure 34. North America DPT Vaccines Revenue Market Share by Type (2017-2028)
    Figure 35. North America DPT Vaccines Sales Market Share by Age (2017-2028)
    Figure 36. North America DPT Vaccines Revenue Market Share by Age (2017-2028)
    Figure 37. North America DPT Vaccines Sales Share by Country (2017-2028)
    Figure 38. North America DPT Vaccines Revenue Share by Country (2017-2028)
    Figure 39. United States DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe DPT Vaccines Sales Market Share by Type (2017-2028)
    Figure 42. Europe DPT Vaccines Revenue Market Share by Type (2017-2028)
    Figure 43. Europe DPT Vaccines Sales Market Share by Age (2017-2028)
    Figure 44. Europe DPT Vaccines Revenue Market Share by Age (2017-2028)
    Figure 45. Europe DPT Vaccines Sales Share by Country (2017-2028)
    Figure 46. Europe DPT Vaccines Revenue Share by Country (2017-2028)
    Figure 47. Germany DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 48. France DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific DPT Vaccines Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific DPT Vaccines Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific DPT Vaccines Sales Market Share by Age (2017-2028)
    Figure 55. Asia Pacific DPT Vaccines Revenue Market Share by Age (2017-2028)
    Figure 56. Asia Pacific DPT Vaccines Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific DPT Vaccines Revenue Share by Region (2017-2028)
    Figure 58. China DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. India DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America DPT Vaccines Sales Market Share by Type (2017-2028)
    Figure 68. Latin America DPT Vaccines Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America DPT Vaccines Sales Market Share by Age (2017-2028)
    Figure 70. Latin America DPT Vaccines Revenue Market Share by Age (2017-2028)
    Figure 71. Latin America DPT Vaccines Sales Share by Country (2017-2028)
    Figure 72. Latin America DPT Vaccines Revenue Share by Country (2017-2028)
    Figure 73. Mexico DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa DPT Vaccines Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa DPT Vaccines Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa DPT Vaccines Sales Market Share by Age (2017-2028)
    Figure 79. Middle East and Africa DPT Vaccines Revenue Market Share by Age (2017-2028)
    Figure 80. Middle East and Africa DPT Vaccines Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa DPT Vaccines Revenue Share by Country (2017-2028)
    Figure 82. Turkey DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE DPT Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 85. DPT Vaccines Value Chain
    Figure 86. DPT Vaccines Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Frequently Asked Questions
DPT Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
DPT Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
DPT Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Rubber Masterbatch

Rubber Masterbatch market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

Motorized Zoom Lens

Motorized Zoom Lens market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More